Patent 12138276
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Active provider: Google · gemini-2.5-flash
PTAB activity (1)
AIA trial proceedings — IPR, PGR, CBM — filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced directly from the PTAB Trial API.
- PGR2025-00076PGRfiled Aug 12, 2025vs. Gilgamesh Pharmaceuticals, Inc. et al.Terminated
Cached for 24 hours. Status strings are sourced verbatim from the PTAB API; the colored badge is our heuristic classification.
Cases on file (1)
Group view →Specific litigation cases in our database that name US patent 12138276. The free-form analysis below may also discuss cases beyond this list.
- PGR2025-00076Patent Trial and Appeal Board (PTAB), United States Patent and Trademark Office (USPTO)Procedural Termination
Defendants: Enveric Biosciences Canada Inc.
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
One known litigation case involving US patent 12138276 is a Post-Grant Review (PGR) proceeding at the Patent Trial and Appeal Board (PTAB) of the USPTO.
Details of the case are as follows:
- Case Number: PGR2025-00076 [cite: original patent text]
- Jurisdiction: Patent Trial and Appeal Board (PTAB), United States Patent and Trademark Office (USPTO) [cite: original patent text]
- Filing Date: Not explicitly available in the provided search results, but the case number indicates it was filed in 2025.
- Plaintiff(s): The petitioner is not explicitly named in the provided search results.
- Defendant(s): The patent owner, Enveric Biosciences Canada Inc., would be the respondent in this PTAB proceeding. [cite: original patent text]
- Outcome or Current Status: Procedural Termination [cite: original patent text]
Generated 5/22/2026, 12:49:04 AM